GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 ...

Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...

non-alcohol fatty liver disease (NAFLD), and other chronic diseases. There are currently 12 GLP-1 agonists approved for use by the U.S. Food and Drug Administration (FDA): Victoza is approved for use ...

Objective To systematically identify and describe self-management interventions for adult patients with chronic kidney disease (CKD). Setting Community-based. Participants Adults with CKD stages 1–5 ...

Over a decade ago, a smattering of studies suggested that early cousins of drugs like Ozempic and Mounjaro ... including heart and kidney disease. The same dynamic may be happening in the brain ...

Most people know that GLP-1 receptor agonist medications like Ozempic and Wegovy ... Those included nausea and vomiting, kidney stones, gastroesophageal reflux disease (GERD), sleep issues ...

Robert F. Kennedy Jr., President Trump’s nominee for Secretary of Health and Human Services, said he will prioritize preventing chronic disease, shifting funding from vaccine and infectious ...

Recent studies highlight side effects such as heart muscle weakening and skin hypersensitivity, along with gastrointestinal issues, pancreatitis, and potential kidney damage. Ozempic and other GLP ...